<?xml version="1.0"?>
<rss version="2.0">
 <channel>
  <title>StreetInsider.com News Articles</title>
  <link>http://streetinsider.com</link>
  <description>Latest StreetInsider.com News Articles</description>
  <language>en-us</language>
  <copyright>Copyright 2026, StreetInsider.com</copyright>
  <managingEditor>rss@streetinsider.com (SI RSS)</managingEditor>
  <webMaster>rss@streetinsider.com (SI RSS)</webMaster>
  <lastBuildDate>Mon, 15 Jun 2026 13:11:00 -0400</lastBuildDate>
  <docs>http://blogs.law.harvard.edu/tech/rss</docs>
  <image>
   <url>http://www.streetinsider.com/images/rss_logo.gif</url>
   <title>StreetInsider.com News Articles</title>
   <link>http://streetinsider.com</link>
   <width>143</width>
   <height>28</height>
  </image>
  <skipHours>
   <hour>0</hour>
   <hour>1</hour>
   <hour>2</hour>
   <hour>3</hour>
   <hour>21</hour>
   <hour>22</hour>
   <hour>23</hour>
  </skipHours>
  <skipDays>
   <day>Saturday</day>
   <day>Sunday</day>
  </skipDays>
  <item>
   <title>Form  20FR12B    Clinuvel Pharmaceuticals             </title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++20FR12B++++Clinuvel+Pharmaceuticals+++++++++++++/26646433.html</link>
   <description>si-local-file:///var/storage/secattach/20260615/26646433.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++20FR12B++++Clinuvel+Pharmaceuticals+++++++++++++/26646433.html</guid>
   <pubDate>Mon, 15 Jun 2026 13:11:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">CLVLF</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CUV</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00706064</category>
   	  </item>
  <item>
   <title>Form  20FR12B    Clinuvel Pharmaceuticals             </title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++20FR12B++++Clinuvel+Pharmaceuticals+++++++++++++/26646433.html</link>
   <description>si-local-file:///var/storage/secattach/20260615/26646433.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++20FR12B++++Clinuvel+Pharmaceuticals+++++++++++++/26646433.html</guid>
   <pubDate>Mon, 15 Jun 2026 13:11:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">CLVLF</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CUV</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00706064</category>
   	  </item>
  <item>
   <title>Form  20FR12B    Clinuvel Pharmaceuticals             </title>
   <link>http://www.streetinsider.com/SEC+Filings/Form++20FR12B++++Clinuvel+Pharmaceuticals+++++++++++++/26646433.html</link>
   <description>si-local-file:///var/storage/secattach/20260615/26646433.html</description>
   <guid isPermaLink="true">http://www.streetinsider.com/SEC+Filings/Form++20FR12B++++Clinuvel+Pharmaceuticals+++++++++++++/26646433.html</guid>
   <pubDate>Mon, 15 Jun 2026 13:11:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">CLVLF</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">CUV</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">O.00706064</category>
   	  </item>
  <item>
   <title>Orthogonal Thinker to acquire majority-owned subsidiary Ei.Ventures</title>
   <link>http://www.streetinsider.com/Mergers+and+Acquisitions/Orthogonal+Thinker+to+acquire+majority-owned+subsidiary+Ei.Ventures/25190682.html</link>
   <description>

&lt;p&gt;Orthogonal Thinker, Inc. announced it has entered into a definitive plan to acquire and consolidate Ei.Ventures, Inc., its majority-owned subsidiary. The transaction is targeted for completion by the end of the first quarter of 2026.&lt;/p&gt;

&lt;p&gt;Ei.Ventures was founded in 2020 to advance health, wellness, and consciousness through psychedelic and plant-based science. Upon closing, all minority shareholders of Ei.Ventures will receive equity in Orthogonal Thinker. The final exchange ratio will be disclosed in formal offer documents anticipated in October 2025.&lt;/p&gt;

&lt;p&gt;Orthogonal Thinker confirmed the transaction will include a premium above relative valuation. The company stated the acquisition represents a step in its multi-year</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Mergers+and+Acquisitions/Orthogonal+Thinker+to+acquire+majority-owned+subsidiary+Ei.Ventures/25190682.html</guid>
   <pubDate>Tue, 12 Aug 2025 21:49:09 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">CLVLF</category>
   	  </item>
  <item>
   <title>Orthogonal Thinker to Acquire Ei.Ventures, Unifying Vision Across Consciousness, Wellness, and AI</title>
   <link>http://www.streetinsider.com/Press+Releases/Orthogonal+Thinker+to+Acquire+Ei.Ventures%2C+Unifying+Vision+Across+Consciousness%2C+Wellness%2C+and+AI/25190681.html</link>
   <description>&lt;p&gt;Honolulu, Hawaii--(Newsfile Corp. - August 12, 2025) - Orthogonal Thinker, Inc. (&quot;&lt;b&gt;Orthogonal&lt;/b&gt;&quot;) today announced it has entered into a definitive plan to acquire and consolidate Ei.Ventures, Inc. (&quot;EI&quot;), its majority-owned subsidiary, into Orthogonal. The transaction, targeted for completion by the end of Q1 2026, represents a cornerstone step in Orthogonal's multi-year strategy to streamline corporate structure, unify investor alignment, and accelerate operational execution across its portfolio.&lt;/p&gt;&lt;p&gt;EI, founded in 2020, was launched to advance health, wellness, and consciousness through psychedelic and plant-based science. While the company's growth trajectory evolved, its intellectual property, network, and early-mover positioning became the foundation for Orthogonal's</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Orthogonal+Thinker+to+Acquire+Ei.Ventures%2C+Unifying+Vision+Across+Consciousness%2C+Wellness%2C+and+AI/25190681.html</guid>
   <pubDate>Tue, 12 Aug 2025 21:47:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">CLVLF</category>
   	  </item>
  <item>
   <title>Orthogonal Thinker to Acquire Ei.Ventures, Unifying Vision Across Consciousness, Wellness, and AI</title>
   <link>http://www.streetinsider.com/Newsfile/Orthogonal+Thinker+to+Acquire+Ei.Ventures%2C+Unifying+Vision+Across+Consciousness%2C+Wellness%2C+and+AI/25190681.html</link>
   <description>&lt;p&gt;Honolulu, Hawaii--(Newsfile Corp. - August 12, 2025) - Orthogonal Thinker, Inc. (&quot;&lt;b&gt;Orthogonal&lt;/b&gt;&quot;) today announced it has entered into a definitive plan to acquire and consolidate Ei.Ventures, Inc. (&quot;EI&quot;), its majority-owned subsidiary, into Orthogonal. The transaction, targeted for completion by the end of Q1 2026, represents a cornerstone step in Orthogonal's multi-year strategy to streamline corporate structure, unify investor alignment, and accelerate operational execution across its portfolio.&lt;/p&gt;&lt;p&gt;EI, founded in 2020, was launched to advance health, wellness, and consciousness through psychedelic and plant-based science. While the company's growth trajectory evolved, its intellectual property, network, and early-mover positioning became the foundation for Orthogonal's</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Newsfile/Orthogonal+Thinker+to+Acquire+Ei.Ventures%2C+Unifying+Vision+Across+Consciousness%2C+Wellness%2C+and+AI/25190681.html</guid>
   <pubDate>Tue, 12 Aug 2025 21:47:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">CLVLF</category>
   	  </item>
 </channel>
</rss>
